Age also showed associations with molecular alterations in IDH1/2-mutant astrocytomas and oligodendrogliomas, where patients <40 years old exhibited distinct correlated molecular alterations compared to those between 40 and 64 and ≥65 years (Figure 3B-C). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).